Heliyon April 2021 PMID 33842709

Clinical characteristics and outcomes of COVID-19 patients with diabetes mellitus in Kuwait.

Abdullah Alshukry, Mohammad Bu Abbas, Yaseen Ali, Barrak Alahmad, Abdullah A Al-Shammari, Ghadeer Alhamar, Mohammad Abu-Farha, Jehad AbuBaker, Sriraman Devarajan, Ali A Dashti, Fahd Al-Mulla, Hamad Ali

Download social card

Mentions

Peak: 1 in Jul 2020

across 3 sources since Jul 2020

Extended reach

5,113

potential audience

Total likes

Video views

177

Mentions per month

Jul 2020 – Aug 2021

Where it's discussed

Bluesky2 posts
X / Twitter1 posts
YouTube1 videos

AI synopsis

What people are saying

Discussions highlight how the study emphasizes the severity of COVID-19 in diabetic patients, mentioning increased ICU admissions and mortality rates, which reflects recognition of serious health implications; words like 'significant' and 'impact' reinforce the importance, while references to similar issues in substance use or transplant recipients show a comparative engagement with related topics.

AgreementModerate agreement

Most discussions acknowledge the significance of the study’s findings regarding worse outcomes for diabetic COVID-19 patients in Kuwait.

InterestModerate interest

Discussions show moderate interest, with references to the impact of comorbidities and blood sugar control on patient outcomes.

EngagementModerate engagement

Comments include mentions of supporting evidence and comparisons with other vulnerable groups, indicating a moderate level of engagement.

ImpactModerate impact

The conversations suggest that the findings are regarded as relevant for clinical practices and public health strategies.

Abstract in brief

Diabetic COVID-19 patients in Kuwait experienced more severe illness, with higher rates of ICU admission (201 vs. 168) and mortality (167 vs. 121) compared to non-diabetic patients, indicating worse clinical outcomes.
These diabetic patients also had more comorbidities like hypertension and showed higher levels of inflammatory markers (C-reactive protein) and lower kidney function, suggesting advanced disease and complications.
A significant finding was that each 1 mmol/L increase in fasting blood glucose raised the odds of death from COVID-19 by approximately 1.52 times, highlighting the impact of blood sugar control on patient prognosis.

Read the full abstract

All mentions

Diabetes and COVID-19: Fasting Blood Glucose's Impact on Severity

The study examines how fasting blood glucose levels relate to COVID-19 severity, revealing nonlinear relationships. Small increases in glucose can significantly elevate the risk of severe outcomes, emphasizing the…

AJE Video Bytes · Aug 19, 2021 177 views

Heliyon

@HeliyonJournal · X

Clinical characteristics and outcomes of COVID-19 patients with diabetes mellitus in Kuwait https://t.co/OCBs7a4Iv0

Apr 12, 2021 · 1 like · 4,936 followers View post →

Society for the Study of Addiction

@addiction-ssa.org · Bluesky

'Clinical impact of COVID-19 on people with substance use disorders' -paper describing the clinical characteristics and outcomes of COVID-19 on people with substance use disorders. | Journal of Public Health (£0) https://buff.ly/37UcwvK

Oct 30, 2020 View post →

Kenar Jhaveri, MD

@kdjhaveri.bsky.social · Bluesky

Clinical Characteristics and Outcomes of COVID-19 in Solid Organ Transplant Recipients: A Case-Control Study https://pubmed.ncbi.nlm.nih.gov/32654332/

Jul 14, 2020 View post →